Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Changes in testing methods for genital Chlamydia trachomatis in New South Wales, Australia, 1999 to 2002

Marcus Y. Chen A B C D and Basil Donovan A B
+ Author Affiliations
- Author Affiliations

A Sydney Sexual Health Centre, Sydney Hospital, GPO Box 1614, Sydney, New South Wales 2001, Australia.

B School of Public Health, University of Sydney, Australia.

C Present address: Melbourne Sexual Health Centre, 580 Swanston St, Carlton, VIC 3053, Australia.

D Corresponding author. Email: mchen@mshc.org.au

Sexual Health 2(4) 251-253 https://doi.org/10.1071/SH04028
Submitted: 21 July 2004  Accepted: 16 June 2005   Published: 16 November 2005

Abstract

Background: Over the last decade, significant advances have occurred in the area of chlamydia diagnostics. The relative frequency of different testing methods employed in the diagnosis of Chlamydia trachomatis infection in New South Wales has not been previously reported. Methods: Testing methods—both laboratory method and specimen type—employed in the diagnosis of chlamydia cases notified in New South Wales between 1999 and 2002 were collated from Health Department records. Results: During a period of increasing notifications, the proportion of men diagnosed with C. trachomatis using nucleic acid tests (NATs) increased from 36% in 1999 to 90% in 2002. Among women, the proportion diagnosed using NATs increased from 42% in 1999 to 92% in 2002. Urine samples were consistently used in the diagnosis of two-thirds of the men, and one-third of the women. Conclusion: Between 1999 and 2002, a rapid shift towards NATs for genital C. trachomatis took place in New South Wales.


Acknowledgements

We acknowledge the HOIST system, Epidemiology and Surveillance Branch, New South Wales Health Department, as the source of data and thank Dr Jeremy McAnulty for his assistance. Marcus Chen is supported by a National Health and Medical Research Council Medical Postgraduate Research Scholarship (262032).


References


[1] Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections – 2002. Morb Mortal Wkly Rep 2002; 51(No. RR-15): 1–27.

[2] Garland SM,  Tabrizi S,  Hallo J,  Chen S. Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy. Sex Transm Infect 2000; 76 173–6.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[3] Knox J,  Tabrizi SN,  Miller P,  Petoumenos K,  Law M,  Chen S, et al. Evaluation of self-collected samples in contrast to practitioner collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis 2002; 29 647–54.
PubMed | | PubMed |

[4] SAS [computer program]. Version 8.2. Cary, NC: SAS Institute Inc; 2001.

[5] Chen M,  Donovan B. Screening for genital Chlamydia trachomatis infection: are men the forgotten reservoir? Med J Aust 2003; 179 124–5.
PubMed | | PubMed | | PubMed |

[6] Garrow SC,  Smith DW,  Harnett GB. The diagnosis of chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice. Sex Transm Infect 2002; 78 278–81.
Crossref | GoogleScholarGoogle Scholar | PubMed | PubMed | PubMed |

[7] Tabrizi SN,  Paterson BA,  Fairley CK,  Bowden FJ,  Garland SM. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int J STD AIDS 1998; 9 347–9.
Crossref | GoogleScholarGoogle Scholar | PubMed | PubMed | PubMed |

[8] Victorian Department of Human Services. Surveillance of notifiable infectious diseases in Victoria 2001. Victoria: Communicable Diseases Section, Rural and Regional Health and Aged Care Services, 2002.

[9] Webster Dicker L,  Mosure DJ,  Steece R,  Stone KM. Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000. Sex Transm Dis 2004; 31 259–64.
PubMed | | PubMed | | PubMed |

[10] Harindra V,  Underhill G,  Tobin JM. Screening for genital chlamydia infection: DNA amplification techniques should be the test of choice. Int J STD AIDS 2003; 14 723–6.
Crossref | GoogleScholarGoogle Scholar | PubMed | PubMed | PubMed |

[11] Grulich AE,  de Visser RO,  Smith AM,  Rissel CE,  Richters J. Sexually transmissible disease and blood borne virus history in a representative sample of adults. Aust N Z J Public Health 2003; 27 234–41.
PubMed | | PubMed | | PubMed |

[12] Götz H,  Lindbäck J,  Ripa T,  Arneborn M,  Ramstedt K,  Ekdahl K. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis 2002; 34 28–34.
Crossref | GoogleScholarGoogle Scholar | PubMed | PubMed | PubMed |